Live Quote · NASDAQREGNHealthcare· Biotechnology

Regeneron Pharmaceuticals, Inc.

$920.69▼ 0.19%($-1.71)
MKT CAP $95.23BNEXT EARNINGS Jan 28, 2027
63%
Bullish
TickerSpark Score
83/100
▌ Strong
73
Valuation
95
Profitability
50
Growth
96
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a REGN research report →

Analyst Price Target
$911.50-1.0% vs. today

Range $756 – $1100

Analyst RatingBuy
34 Buy15 Hold0 Sell

Price Chart

+31.39% · this period
$973.36$787.01$600.66Nov 19May 22Nov 19
52-Week Range82% of range
Low
$591.52
Current
$920.69
High
$991.73

AI analysis · Last refreshed November 15, 2026 · Live quote · Not investment advice